Preferred Label : mometasone furoate monohydrate;

UMLS semantic type : T110 - Steroid; T121 - Pharmacologic Substance;

CAS number : MTW0WEG809;

Is substance : O;

UNII : MTW0WEG809;

InChIKey : AQCCVUHZMIMSIB-HRVPQZBTSA-N;

Details


Main resources

You can consult :


http://www.has-sante.fr/portail/jcms/c_2747016/fr/nasonex
2017
false
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Mometasone Furoate
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
nasal polyps
treatment outcome
anti-allergic agents
mometasone furoate monohydrate
mometasone
anti-inflammatory agents
insurance, health, reimbursement
adult
adolescent
child
nasal sprays
administration, intranasal

---
http://www.has-sante.fr/portail/jcms/c_1283974/nasonex
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/nasonex_18072012_avis_ct12208.pdf
http://www.has-sante.fr/portail/jcms/c_539613/nasonex
http://www.has-sante.fr/portail/jcms/c_400668/nasonex-50-microgrammes/dose-suspension-pour-pulverisation-nasale-flacon-de-120-doses-code-cip-343-012-6
http://www.has-sante.fr/portail/jcms/c_399576/nasonex-50-g/dose-suspension-pour-pulverisation-nasale-flacon-de-120-doses
2012
false
France
French
evaluation of the transparency committee
corticosteroid therapy
Mometasone Furoate
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
nasal polyps
treatment outcome
anti-allergic agents
mometasone furoate monohydrate
mometasone
anti-inflammatory agents
insurance, health, reimbursement
adult
adolescent
child
nasal sprays
administration, intranasal

---
http://www.lecrat.eu/?s=Mom%C3%A9tasone
2007
false
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Mometasone Furoate
anti-inflammatory agents
glucocorticoids
pregnancy
breast feeding
mometasone
mometasone furoate monohydrate
administration, intranasal
drug information

---
Nous contacter.
06/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.